Related Experiment Video

Updated: Feb 15, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

2.9K

Mycoplasma pneumoniae and toll-like receptors: A mutual avenue

M Naghib1, M Hatam-Jahromi1, M Niktab1

  • 1Department of Microbiology, Kerman Branch, Islamic Azad University, Kerman, Iran.

Allergologia Et Immunopathologia
|January 15, 2018
PubMed

Insights

Toll-like receptors (TLRs) play a dual role in Mycoplasma pneumoniae infections, mediating both pathogen clearance and disease complications. Understanding TLRs is key to managing M. pneumoniae-related health issues.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Mycoplasma pneumoniae is an intracellular bacterium causing human infections with variable outcomes.
  • The mechanisms underlying M. pneumoniae clearance versus complication induction remain unclear.
  • Toll-like receptors (TLRs) are crucial in pathogen recognition and immune response modulation.

Purpose of the Study:

  • To review current data on the role of Toll-like receptors (TLRs) in Mycoplasma pneumoniae infections.
  • To elucidate how TLRs contribute to both the eradication of M. pneumoniae and the development of associated complications.

Main Methods:

  • Literature review of recent studies on TLRs and M. pneumoniae.
  • Analysis of immune response pathways involving TLRs in M. pneumoniae pathogenesis.
  • Synthesis of data on TLRs' dual role in infection outcomes.

Main Results:

  • TLRs recognize M. pneumoniae components, initiating immune responses.
  • Evidence suggests TLRs are involved in both clearing the infection and causing inflammatory complications.
  • Specific TLRs and their downstream signaling pathways influence disease severity.

Conclusions:

  • Toll-like receptors are critical mediators in the host response to Mycoplasma pneumoniae.
  • Targeting TLR pathways may offer therapeutic strategies for managing M. pneumoniae infections and complications.
Keywords:
ComplicationsMycoplasma pneumoniaeToll-like receptor

More Related Videos

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation09:04

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation

Published on: September 7, 2010

12.0K
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

13.0K

Related Concept Videos

Mutual Inductance01:24

Mutual Inductance

Inductance is the property of a device that tells us how effectively it induces an emf in another device. In other words, it is a physical quantity that expresses the effectiveness of a given device.
When two circuits carrying time-varying currents are close to one another, the magnetic flux through each circuit varies because of the changing current in the other circuit. Consequently, an emf is induced in each circuit by the changing current in the other. Therefore, this type of emf is called...
3.9K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
932
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.1K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
835
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.8K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.6K